8 results
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... for Management ... of Eosinophilic Granulomatosis ... #Eosinophilic #Granulomatosis ... #rheumatology #algorithm
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... for Management ... of Granulomatosis ... #MPA #ACR2021 #Management ... #rheumatology #algorithm
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... Nodosa (PAN) • Granulomatosis ... • Eosinophilic Granulomatosis ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #algorithm #rheumatology
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... Guideline *With ... Effusions #MPE #Algorithm ... #Management #ATS ... #Guidelines
Clinical Algorithm for Emergency Department Evaluation and Management of UTI in Febrile Infants and Young Children

Urinary
Evaluation and Management ... Guidelines are based ... Guidelines are not ... #UTI #Algorithm ... #Diagnosis #Management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... Guideline *With ... used as a rough guideline ... #Algorithm #Effusion ... #Malignant #Management